Rome R. M., England P. G.
Royal Women's and Freemason's Hospitals, Melbourne, Australia.
Int J Gynecol Cancer. 2000 Sep;10(5):382-390. doi: 10.1046/j.1525-1438.2000.010005382.x.
A series of 132 cases of vaginal intraepithelial neoplasia (VAIN) is presented, including nine (6.8%) where early invasive carcinoma of the vagina was found in the course of initial management of the VAIN. The majority of patients (75%) had high-grade VAIN (two or three). Seventy-two (55%) had undergone a prior hysterectomy; 22 for preinvasive disease (CIN), 33 for invasive gynecological cancer, 13 for benign reasons, and in 4 the reason for the hysterectomy and/or the Pap smear history was not known. Twenty-one (16%) had received prior pelvic radiotherapy. VAIN was noted to involve either the vaginal vault (in the post-hysterectomy group) or the upper vagina (in the no hysterectomy group) in more than 80% cases. A variety of treatment modalities was used with varying degrees of success. For high-grade VAIN excisional treatments had an overall (first-line plus subsequent) cure rate of 69% (53/77). The state of the surgical margins did not correlate with the risk of residual disease. CO2 laser ablation was curative in 69% (18/26) of cases and was significantly better than electrocoagulation diathermy which was curative in only 25% (3/12) of cases (P = 0.013). Five-fluorouracil cream was curative in 46% (5/11) of cases, including four patients who had received prior radiotherapy. Radiotherapy was effective in eradicating VAIN in the two cases where it was used as the primary treatment modality. Progression of high-grade VAIN to invasive cancer occurred in eight (8%) cases; after no treatment in two cases, after treatment failure in five cases, and as a late recurrence in one case. For low-grade VAIN an observational approach after biopsy was initially adopted in eight patients and regression occurred in seven (88%) of these patients. Other miscellaneous treatments were also effective in low-grade VAIN. These data provide evidence that high-grade VAIN is a precursor to invasive cancer of the vagina and every attempt should be made to eradicate it. Based on our experience and a review of the literature we have proposed a plan for optimal management of this condition.
本文报告了132例阴道上皮内瘤变(VAIN)病例,其中9例(6.8%)在VAIN初始治疗过程中发现早期阴道浸润癌。大多数患者(75%)患有高级别VAIN(二级或三级)。72例(55%)患者曾接受过子宫切除术;22例因癌前病变(CIN)行子宫切除术,33例因妇科浸润癌行子宫切除术,13例因良性原因行子宫切除术,4例子宫切除术和/或巴氏涂片检查史不明。21例(16%)患者曾接受盆腔放疗。在超过80%的病例中,VAIN累及阴道穹窿(子宫切除术后组)或阴道上段(未行子宫切除组)。采用了多种治疗方式,疗效各异。对于高级别VAIN,切除性治疗的总体(一线治疗加后续治疗)治愈率为69%(53/77)。手术切缘状态与残留疾病风险无关。CO2激光消融治疗的治愈率为69%(18/26),明显优于电凝透热疗法,后者治愈率仅为25%(3/12)(P = 0.013)。5-氟尿嘧啶乳膏治疗的治愈率为46%(5/11),其中包括4例曾接受放疗的患者。放疗作为主要治疗方式用于2例患者时,有效根除了VAIN。高级别VAIN进展为浸润癌的有8例(8%);2例未治疗,5例治疗失败,1例为晚期复发。对于低级别VAIN,最初对8例患者活检后采用观察法,其中7例(88%)病情缓解。其他杂项治疗对低级别VAIN也有效。这些数据表明高级别VAIN是阴道浸润癌的前驱病变,并应尽一切努力根除它。基于我们的经验和文献回顾,我们提出了针对该疾病的最佳管理方案。